Sindu Kanjeekal, MD, FRCP(C)

Position: Medical Oncologist; Chief, Department of Oncology
Affiliation: Windsor Regional Cancer Program

Website: www.wrh.on.ca/cancerprogram

Areas of Expertise: Internal Medicine, Hematology, Medical Oncology

Brief Description of Research:

Dr. Sindu Kanjeekal is active in clinical research with a focus on Genitourinary and Hematologic Cancers. She is involved in studies that investigate different aspects of cancer development and clinical behavior including cancer cell biology, clinical trials for myeloma and lymphoma therapeutics, to socioeconomic indicators impacting cancer treatment and outcome.

Dr. Kanjeekal is the Principal Investigator on a Seeds4Hope Grant: Identifying a genetic signature that predicts progression of non-invasive urothelial (bladder) carcinoma to an invasive cancer. It was her clinical experience treating patients with advanced bladder cancer that motivated her to focus on research that will contribute to our understanding of bladder cancer progression. She also collaborates with other clinicians and basic scientists to help develop local cancer initiatives. She is a member of the Myeloma Cancer Research Network, a national organization that focuses on advancements in Myeloma research.

5 Select Publications (Students/personnel are underlined):

Blaszak, M., El‑Masri, M., Hirmiz, K., Mathews, J., Omar, A., Elfiki, T., Gupta, R., Hamm, C., Kanjeekal, S., Kay, A., Kulkarni, S., Ghafoor, A. (2017). Survival of Patients with Pancreatic Cancer Treated with Varied Modalities: A Single-Centre Study. Molecular and clinical oncology 6(4), 583-588.

Chan, R. J., Gupta, R., Kanjeekal, S. M., Jarrar, M., Kay, A., Mathews, J., … & Hamm, C. M. (2016). Diffuse Large B-cell Lymphoma: A Single-Institution Experience of Patient Outcomes. Journal of Clinical Oncology.

Gorey, K. M., Bartfay, E., Kanjeekal, S. M., Wright, F. C., Hamm, C., Luginaah, I. N., … & Balagurusamy, M. K. (2016). Palliative Chemotherapy Among People Living in Poverty with Metastasised Colon Cancer: Facilitation by Primary Care and Health Insurance. BMJ supportive & palliative care, bmjspcare-2015.

Ward, A., Sivakumar, G., Kanjeekal, S., Hamm, C., Labute, B. C., Shum, D., & Hudson, J. W. (2015). The Deregulated Promoter Methylation of the Polo-like Kinases as a Potential Biomarker in Hematological Malignancies.Leukemia & lymphoma 56(7), 2123-2133.

Holowaty, E. J., Wright, F. C., Hamm, C., & Kanjeekal, S. M. (2011). Effects of Socioeconomic Status on Colon Cancer Treatment Accessibility and Survival in Toronto, Ontario, and San Francisco, California, 1996-2006. American Journal of Public Health 101(1), 112.